Life Science REIT PLC
LSE:LABS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Life Science REIT PLC
Total Equity
Life Science REIT PLC
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
L
|
Life Science REIT PLC
LSE:LABS
|
Total Equity
£262.8m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Primary Health Properties PLC
LSE:PHP
|
Total Equity
£2.6B
|
CAGR 3-Years
20%
|
CAGR 5-Years
13%
|
CAGR 10-Years
22%
|
|
|
Assura PLC
LSE:AGR
|
Total Equity
£1.6B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
|
Target Healthcare REIT PLC
LSE:THRL
|
Total Equity
£740.3m
|
CAGR 3-Years
5%
|
CAGR 5-Years
8%
|
CAGR 10-Years
16%
|
|
Life Science REIT PLC
Glance View
Life Science Reit Plc is an investment company, which intends to carry on business as a REIT. The Company’s investment objective is to provide shareholders with a level of total return. The company will seek to achieve its investment objective by investing in a diversified portfolio of properties across the United Kingdom which are leased or intended to be leased to tenants operating in, or providing a benefit to, the life science sector. The company acquires or develops properties, such as wet and dry laboratories, offices, incubators and co-working space, manufacturing and testing facilities and data centers. The company acquires individual buildings, a group of buildings across a single science park or the entirety of a science park. This may include purchasing or developing buildings that are leased or intended to be leased to tenants providing ancillary services to employees of companies operating in, or providing a benefit to, the life science sector. The Company’s investment adviser is Ironstone Asset Management Limited.
See Also
What is Life Science REIT PLC's Total Equity?
Total Equity
262.8m
GBP
Based on the financial report for Dec 31, 2024, Life Science REIT PLC's Total Equity amounts to 262.8m GBP.
What is Life Science REIT PLC's Total Equity growth rate?
Total Equity CAGR 3Y
-9%
Over the last year, the Total Equity growth was -7%. The average annual Total Equity growth rates for Life Science REIT PLC have been -9% over the past three years .